Table 3 Analyses of measures other than symptoms of depression.

From: The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial

 

PReDicT group

TaU group

  

Time point

N

Mean change (95% CI)

N

Mean change (95% CI)

Difference between groups (95% CI)

P value

GAD-7

Week 8

391

−6.12 (−6.83, −5.41)

389

−5.44 (−6.14, −4.74)

0.68 (0.03, 1.32)

0.040

SAS-SR

Week 8

391

−7.60 (−8.57, −6.64)

389

−6.51 (−7.47, −5.54)

1.09 (−0.26, 2.45)

0.112

Week 24

274

−9.70 (−10.79, −8.61)

258

−7.48 (−8.60, −6.36)

2.22 (0.74, 3.70)

0.004

Week 48

228

−10.28 (−11.50, −9.05)

231

−9.60 (−10.81, −8.39)

0.68 (−0.73, 2.08)

0.346

  1. Significant results highlighted in bold. GAD-7 Generalised Anxiety Disorder Assessment, 7-item version, SAS-SR Social Adjustment Scale, self-report screener form, T-score (note a higher score indicates greater impairment).
Back to article page